These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7093103)

  • 41. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM; Kumana CR; Franklin DA; Baker LR
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.
    Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K
    Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.
    Pedersen EB; Larsen JS
    Postgrad Med J; 1980; 56 Suppl 2():27-32. PubMed ID: 7433339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP; Leroy A; Moulin B; Dhib M; Borsa-Lebas F; Humbert G
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of cefonicid in uraemic patients.
    Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
    J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of pefloxacin in renal insufficiency.
    Montay G; Jacquot C; Bariety J; Cunci R
    Eur J Clin Pharmacol; 1985; 29(3):345-9. PubMed ID: 3865778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
    Bonati M; Traina GL; Rosina R; Buniva G
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis.
    Fillastre JP; Taburet AM; Fialaire A; Etienne I; Bidault R; Singlas E
    Drugs Exp Clin Res; 1993; 19(1):25-32. PubMed ID: 8223137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetics of intravenous Cefradin in normal and restricted renal function (author's transl)].
    Höffler D; Koeppe P
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1169-74. PubMed ID: 808712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.
    Berglund G; Descamps R; Thomis JA
    Eur J Clin Pharmacol; 1980 Oct; 18(4):321-6. PubMed ID: 7439252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of amikacin in patients with renal insufficiency: relation of half-life and creatinine clearance.
    Pijck J; Hallynck T; Soep H; Baert L; Daneels R; Boelaert J
    J Infect Dis; 1976 Nov; 134 SUPPL():S331-41. PubMed ID: 993626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
    Humbert G; Leroy A; Fillastre JP; Godin M
    Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bumetanide kinetics in renal failure.
    Pentikäinen PJ; Pasternack A; Lampainen E; Neuvonen PJ; Penttilä A
    Clin Pharmacol Ther; 1985 May; 37(5):582-8. PubMed ID: 3987182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of nomifensine in impaired renal function.
    Ringoir S; Lameire N; Munche M; Heptner W; Taeuber K
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):129S-134S. PubMed ID: 334214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antipyrine kinetics in Nigerian women in chronic renal failure.
    Iyun AO; Tucker GT
    Afr J Med Med Sci; 1982 Mar; 11(1):7-9. PubMed ID: 6291357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of renal function between open and endovascular aneurysm repair in patients with baseline chronic renal insufficiency.
    Parmer SS; Fairman RM; Karmacharya J; Carpenter JP; Velazquez OC; Woo EY
    J Vasc Surg; 2006 Oct; 44(4):706-11. PubMed ID: 16930930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of labetalol and methyldopa on renal function.
    Cruz F; O'Neill WM; Clifton G; Wallin JD
    Clin Pharmacol Ther; 1981 Jul; 30(1):57-63. PubMed ID: 7237899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of the combination of ticarcillin with clavulanic acid in renal insufficiency.
    Dalet F; Amado E; Cabrera E; Donate T; del Rio G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():57-64. PubMed ID: 3722047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.